Robotic‐assisted completion cholecystectomy: A safe and effective approach to a challenging surgical scenario – A single center retrospective cohort study. Issue 6 (19th July 2021)

• Record Type: Journal Article
• Authors: Tschuor, Christoph; Lyman, William B.; Passeri, Michael; Salibi, Patrick N.; Baimas‐George, Maria; Iannitti, David A.; Baker, Erin H.; Vrochides, Dionisios; Martinie, John B.
• Is Part Of: International journal of medical robotics and computer assisted surgery. Volume 17:Issue 6(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-07-19
• Subjects: completion cholecystectomy -- robotic -- robotic‐assisted surgery -- subtotal cholecystectomy; Robotics in medicine -- Periodicals; Surgery -- Technological innovations -- Periodicals; Imaging systems in medicine -- Periodicals; 617.90285
• DOI: 10.1002/rcs.2312
• Languages: English
• ISSNs: 1478-5951

Abstract

Abstract: Background: Reoperation following a previous subtotal or aborted cholecystectomy presents a challenging surgical scenario that has traditionally required an open completion cholecystectomy. The aim of this study was to describe an institutional experience with a robotic‐assisted approach to completion cholecystectomy. Methods: A database was retrospectively audited to identify all patients who underwent robotic‐assisted cholecystectomy performed by two hepatopancreatobiliary surgeons at a single centre from 2010 to 2019. Results: Twenty six patients who underwent a robotic‐assisted completion cholecystectomy were identified. Median operative time was 142 min (48–247 min) with a blood loss of 50 cc (0–500 cc). Minor complications (Clavien–Dindo ≤ II 90 days) occurred in three patients (11.5%) with no major complication or mortality reported. Median hospital length of stay was 1 day (0–6 days) with one patient readmitted. Conclusion: This study represents to our knowledge the largest series of robotic‐assisted completion cholecystectomies to date. The robotic approach appears to be a safe and effective procedure associated with a low morbidity and high success rate.